J. Greg Slatter

2.9k citations
50 papers · 2.0k · h-index 21

Impact in

  • Pharmacology top 0.5%
    • Pharmacogenetics and Drug Metabolism
    • Drug-Induced Hepatotoxicity and Protection
  • Oncology top 5%
    • Drug Transport and Resistance Mechanisms

Papers in

  • Pharmacology 18
    • Pharmacogenetics and Drug Metabolism 18
    • Drug-Induced Hepatotoxicity and Protection 5
  • Molecular Biology 15
    • PI3K/AKT/mTOR signaling in cancer 6
Co-authors
Thomas A. Baillie (7 shared papers)Larry C. Wienkers (5 shared papers)Leslie J. Dickmann (5 shared papers)Sonal Patel (3 shared papers)Paul G. Pearson (8 shared papers)James P. Sams (2 shared papers)Larry J. Schaaf (2 shared papers)Roger G. Ulrich (6 shared papers)
Journals
Xenobiotica (8 papers)Drug Metabolism and Disposition (7 papers)Journal of Clinical Oncology (4 papers)Chemical Research in Toxicology (3 papers)The Journal of Clinical Pharmacology (3 papers)
Partner nations
United StatesJapanUnited Kingdom

In The Last Decade

J. Greg Slatter

49 papers receiving 1.9k citations

Peers

J. Greg Slatter
Comparison fields: 5 of 113
  • Pharmacology 496
  • Oncology 574
  • Biochemistry 122
  • Genetics 152
  • Pharmaceutical Science 72
Replace Joseph A. Ware with:
Joseph A. Ware United States
Bernard P. Murray United States
Jurjen S. Lagas Netherlands
Cho‐Ming Loi United States
Mark J. Dresser United States
Robert A.B. van Waterschoot Netherlands
David Jones United States
Jan Snoeys Belgium
David R. Jones United States
Leslie J. Dickmann United States
J. Greg Slatter relative to Joseph A. Ware United States Joseph A. Ware's profile →
Citations per field
00.5×1.5×1.8×
Joseph A. Ware · 1×
Citations per year

Countries citing papers authored by J. Greg Slatter

Since Specialization
Citations

This map shows the geographic impact of J. Greg Slatter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Greg Slatter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Greg Slatter more than expected).

Fields of papers citing papers by J. Greg Slatter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Greg Slatter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Greg Slatter. The network helps show where J. Greg Slatter may publish in the future.

Co-authors

The 25 scholars most cited alongside J. Greg Slatter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Greg Slatter Line = papers co-authored together J. Greg Slatter links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients
Drug Metabolism and Disposition ·J. Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, K. S. Cathcart, Michael T. Verburg, Laura Pearson, Linda D. Compton, Langdon L. Miller, David Baker, Caroline V. Pesheck, Raymond S. Lord
2000242
2
Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: A resource for investigations into drug disposition
Xenobiotica ·Kelly Bleasby, John C. Castle, C. J. Roberts, Chunzhen Cheng, Wendy J. Bailey, Joseph F. Sina, Amit Kulkarni, Mike Hafey, Raymond Evers, Jason M. Johnson, Roger G. Ulrich, J. Greg Slatter
2006217
3
Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver
Genome Research ·Xia Yang, Bin Zhang, Cliona Molony, Eugene Chudin, Ke Hao, Jun Zhu, Andrea Gaedigk, Christine Suver, Hua Zhong, J. Steven Leeder, F. Peter Guengerich, Stephen C. Strom, Erin G. Schuetz, Thomas H. Rushmore, Roger G. Ulrich, J. Greg Slatter, Eric E. Schadt, Andrew Kasarskis, Pek Yee Lum
2010212
4
Effects of Interleukin-6 (IL-6) and an Anti-IL-6 Monoclonal Antibody on Drug-Metabolizing Enzymes in Human Hepatocyte Culture
Drug Metabolism and Disposition ·Leslie J. Dickmann, Sonal Patel, Dan A. Rock, Larry C. Wienkers, J. Greg Slatter
2011146
5
Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions.
PubMed ·J. Greg Slatter, Ping Su, James P. Sams, Larry J. Schaaf, Larry C. Wienkers
1997129
6
Glutathione: a vehicle for the transport of chemically reactive metabolites in vivo
Accounts of Chemical Research ·Thomas A. Baillie, J. Greg Slatter
199197
7
Biotransformation of methyl isocyanate in the rat. Evidence for glutathione conjugation as a major pathway of metabolism and implications for isocyanate-mediated toxicities
Chemical Research in Toxicology ·J. Greg Slatter, Mohamed S. Rashed, Paul G. Pearson, Deog Hwa Han, Thomas A. Baillie
199189
8
Effects of Interleukin 1β (IL-1β) and IL-1β/Interleukin 6 (IL-6) Combinations on Drug Metabolizing Enzymes in Human Hepatocyte Culture
Current Drug Metabolism ·Leslie J. Dickmann, Sonal Patel, Larry C. Wienkers, J. Greg Slatter
201262
9
Critical Review of Preclinical Approaches to Investigate Cytochrome P450–Mediated Therapeutic Protein Drug-Drug Interactions and Recommendations for Best Practices: A White Paper
Drug Metabolism and Disposition ·Raymond Evers, Shannon Dallas, Leslie J. Dickmann, Odette A. Fahmi, Jane R. Kenny, Eugenia Kraynov, Theresa V. Nguyen, Aarti Patel, J. Greg Slatter, Lei Zhang
201360
10
Bioavailability, Biotransformation, and Excretion of the Covalent Bruton Tyrosine Kinase Inhibitor Acalabrutinib in Rats, Dogs, and Humans
Drug Metabolism and Disposition ·Terry Podoll, Paul G. Pearson, Jerry Evarts, Tim Ingallinera, Елена Бибикова, Hao Sun, Mark Gohdes, Kristen A. Cardinal, Mitesh Sanghvi, J. Greg Slatter
201853
11
S-(N-Methylcarbamoyl)glutathione: A reactive S-linked metabolite of methyl isocyanate
Biochemical and Biophysical Research Communications ·Paul G. Pearson, J. Greg Slatter, Mohamed S. Rashed, Deog-Hwa Han, Mark P. Grillo, Thomas A. Baillie
199052
12
Carbamoylation of peptides and proteins in vitro by S-(N-methylcarbamoyl)glutathione and S-(N-methylcarbamoyl)cysteine, two electrophilic S-linked conjugates of methyl isocyanate
Chemical Research in Toxicology ·Paul G. Pearson, J. Greg Slatter, Mohamed S. Rashed, Deog Hwa Han, Thomas A. Baillie
199148
13
Metabolism and related human risk factors for hepatic damage by usnic acid containing nutritional supplements
Xenobiotica ·R. Foti, Leslie J. Dickmann, John A. Davis, Robert J. Greene, John J. Hill, Monique Howard, Josh T. Pearson, Dan A. Rock, J. C. Tay, Jan L. Wahlstrom, J. Greg Slatter
200845
14
Bridging in vitro dissolution and in vivo exposure for acalabrutinib. Part II. A mechanistic PBPK model for IR formulation comparison, proton pump inhibitor drug interactions, and administration with acidic juices
European Journal of Pharmaceutics and Biopharmaceutics ·Xavier Pépin, Andrea Moir, James Mann, Natalie Sanderson, Richard A. Barker, E. J. Meehan, A. Philip Plumb, George R. Bailey, Dean Murphy, Cecile M. Krejsa, Marilee Andrew, Timothy G. Ingallinera, J. Greg Slatter
201941
15
PROFILING THE HEPATIC EFFECTS OF FLUTAMIDE IN RATS: A MICROARRAY COMPARISON WITH CLASSICAL ARYL HYDROCARBON RECEPTOR LIGANDS AND ATYPICAL CYP1A INDUCERS
Drug Metabolism and Disposition ·Kevin J. Coe, Sidney D. Nelson, Roger G. Ulrich, Yudong D. He, Xudong Dai, Olivia Cheng, Michelle J. Caguyong, Chris Roberts, J. Greg Slatter
200640
16
Evaluation of the Drug–Drug Interaction Potential of Acalabrutinib and Its Active Metabolite, ACP‐5862, Using a Physiologically‐Based Pharmacokinetic Modeling Approach
CPT Pharmacometrics & Systems Pharmacology ·Diansong Zhou, Terry Podoll, Yan Xu, Ganesh Moorthy, Karthick Vishwanathan, Joseph A. Ware, J. Greg Slatter, Nidal Al‐Huniti
201939
17
In Vitro Metabolic Activation of Lumiracoxib in Rat and Human Liver Preparations
Drug Metabolism and Disposition ·Ying Li, J. Greg Slatter, Zhoupeng Zhang, Yan Li, George A. Doss, Matthew P. Braun, Ralph A. Stearns, Dennis Dean, Thomas A. Baillie, Wei Tang
200734
18
Therapeutic Protein Drug–Drug Interactions: Navigating the Knowledge Gaps–Highlights from the 2012 AAPS NBC Roundtable and IQ Consortium/FDA Workshop
The AAPS Journal ·Jane R. Kenny, Maggie M. Liu, Andrew Chow, Justin Earp, Raymond Evers, J. Greg Slatter, Diane D. Wang, Lei Zhang, Honghui Zhou
201333
19
Microarray-based compendium of hepatic gene expression profiles for prototypical ADME gene-inducing compounds in rats and micein vivo
Xenobiotica ·J. Greg Slatter, Olivia Cheng, Paul D. Cornwell, Andrea de Souza, John C Rockett, Thomas H. Rushmore, Dylan P. Hartley, Raymond Evers, Yudong D. He, Xudong Dai, Raymond Hu, Michelle J. Caguyong, Chris Roberts, John C. Castle, Roger G. Ulrich
200629
20
Compendium of gene expression profiles comprising a baseline model of the human liver drug metabolism transcriptome
Xenobiotica ·J. Greg Slatter, Ian E. Templeton, John C. Castle, Amit Kulkarni, Thomas H. Rushmore, Karen Richards, Yudong D. He, Xudong Dai, Olivia Cheng, Michelle J. Caguyong, Roger G. Ulrich
200626

About J. Greg Slatter

J. Greg Slatter is a scholar working on Pharmacology, Molecular Biology, Genetics, Oncology and Pathology and Forensic Medicine, having authored 50 papers that have together received 2.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (18 papers), Chronic Lymphocytic Leukemia Research (14 papers), Lymphoma Diagnosis and Treatment (10 papers), Computational Drug Discovery Methods (7 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Drug Transport and Resistance Mechanisms (6 papers), Drug-Induced Hepatotoxicity and Protection (5 papers) and Sulfur Compounds in Biology (5 papers). The work is most often cited by research in Pharmacology (496 citations), Oncology (574 citations), Biochemistry (122 citations), Genetics (152 citations) and Pharmaceutical Science (72 citations). J. Greg Slatter has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Thomas A. Baillie, Larry C. Wienkers, Leslie J. Dickmann, Sonal Patel, Paul G. Pearson, James P. Sams, Larry J. Schaaf, Roger G. Ulrich, Mohamed S. Rashed and Dan A. Rock. Their work appears in journals such as Xenobiotica, Drug Metabolism and Disposition, Journal of Clinical Oncology, Chemical Research in Toxicology and The Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph A. WareBreakdown of academic impact, for papers by Bernard P. MurrayBreakdown of academic impact, for papers by Jurjen S. LagasBreakdown of academic impact, for papers by Cho‐Ming LoiBreakdown of academic impact, for papers by Mark J. DresserBreakdown of academic impact, for papers by Robert A.B. van WaterschootBreakdown of academic impact, for papers by David JonesBreakdown of academic impact, for papers by Jan SnoeysBreakdown of academic impact, for papers by David R. JonesBreakdown of academic impact, for papers by Leslie J. Dickmann